SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-23-019881
Filing Date
2023-07-13
Accepted
2023-07-13 16:32:24
Documents
16

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 dffn20230712c_424b3.htm 424B3 6031667
2 cglogo.jpg GRAPHIC 9347
3 dp01.jpg GRAPHIC 7518
4 eippharma01.jpg GRAPHIC 7573
5 graph01.jpg GRAPHIC 12989
6 graph02.jpg GRAPHIC 17525
7 graph04.jpg GRAPHIC 23632
8 graph05.jpg GRAPHIC 43499
9 graph07.jpg GRAPHIC 13761
10 graph08.jpg GRAPHIC 19130
11 graph09.jpg GRAPHIC 36727
12 graph10.jpg GRAPHIC 25635
13 graph11.jpg GRAPHIC 15172
14 graph12.jpg GRAPHIC 15839
15 pic1.jpg GRAPHIC 71589
16 pic2.jpg GRAPHIC 75736
  Complete submission text file 0001437749-23-019881.txt   6579438
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271823 | Film No.: 231087095
SIC: 2834 Pharmaceutical Preparations